Barclays analyst Jack Meehan maintained a Hold rating on Waters Corp (WAT) yesterday and set a price target of $200. The company’s shares closed yesterday at $223.71, close to its 52-week high of $230.18.
According to TipRanks.com, Meehan is a 4-star analyst with an average return of 5.0% and a 58.0% success rate. Meehan covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, Syneos Health Inc, and Myriad Genetics.
Currently, the analyst consensus on Waters Corp is a Hold with an average price target of $202.71, implying a -9.4% downside from current levels. In a report released yesterday, Robert W. Baird also downgraded the stock to Hold with a $211 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $230.18 and a one-year low of $167.94. Currently, Waters Corp has an average volume of 632.2K.
Based on the recent corporate insider activity of 43 insiders, corporate insider sentiment is negative on the stock. Most recently, in December 2018, Edward Conard, a Director at WAT bought 3,500 shares for a total of $133,315.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Waters Corp. is a specialty measurement company, which engages in the analytical workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis innovations. It operates through Waters and TA segments.
